Nautic Partners’ Investment in EmpiRx Health

Fried, Frank, Harris, Shriver & Jacobson represented EmpiRx, while McDermott Will & Emery represented Nautic in the transaction.

EmpiRx Health (EmpiRx) closed a strategic growth investment from Nautic Partners (Nautic). The new partnership will further EmpiRx’s investment in tech-enabled clinical innovation and care models, while expanding its reach in the market to those who need differentiated pharmacy solutions that drive improved patient quality and access, while lowering the total cost of healthcare.

EmpiRx is the industry’s only value-based pharmacy benefit manager (PBM) with a clinically-focused and tech-enabled approach to bending the Rx cost curve. Nautic is a private equity firm focused on leveraged buyout investment in middle-market companies.

The Fried Frank team was led by corporate partner Philip Richter (Picture) and included corporate partner Roy Tannenbaum; executive compensation & ERISA partner Jeffrey Ross; tax partner Michael J. Alter; corporate special counsel Howard A. Fine; antitrust and competition special counsel Aleksandr B. Livshits; corporate associates Meka Jegede, R. Kirkie Maswoswe, and Brianna N. Schacter; antitrust and competition associate Summer K. Quintana; and tax associate Karen Li.

Involved fees earner: Michael Alter – Fried Frank Harris Shriver & Jacobson; Howard A. Fine – Fried Frank Harris Shriver & Jacobson; Meka Jegede – Fried Frank Harris Shriver & Jacobson; Karen Li – Fried Frank Harris Shriver & Jacobson; Aleksandr Livshits – Fried Frank Harris Shriver & Jacobson; R. Kirkie Maswoswe – Fried Frank Harris Shriver & Jacobson; Summer Quintana – Fried Frank Harris Shriver & Jacobson; Philip Richter – Fried Frank Harris Shriver & Jacobson; Jeffrey Ross – Fried Frank Harris Shriver & Jacobson; Brianna Schacter – Fried Frank Harris Shriver & Jacobson; Roy Tannenbaum – Fried Frank Harris Shriver & Jacobson;

Law Firms: Fried Frank Harris Shriver & Jacobson;

Clients: EmpiRx Health;

Author: Martina Bellini